妊娠期胎盘及母胎界面中严重急性呼吸综合征冠状病毒2细胞进入基因血管紧张素转换酶2与跨膜丝氨酸蛋白酶2在早产或子痫前期妊娠中的表达
本研究纳入两个独立队列共87例妊娠,检测胎盘及母胎界面血管紧张素转换酶2(ACE2)与跨膜丝氨酸蛋白酶2(TMPRSS2)mRNA表达。第一队列显示ACE2与TMPRSS2表达随孕龄变化,早孕期胎盘高于中孕期、早产及足月胎盘(P<.05),与孕龄呈负相关(P<.05)。第二队列显示早产、子痫前期及足月蜕膜和晚孕期胎盘中ACE2表达极低或检测不到,TMPRSS2在蜕膜和胎盘均有表达但在早产或子痫前期妊娠中无变化。
要点
- 早孕期胎盘ACE2与TMPRSS2 mRNA表达高于中孕期、早产及足月胎盘(P<.05)。
- 早产、子痫前期及足月蜕膜和晚孕期胎盘中ACE2表达极低或检测不到。
- TMPRSS2在蜕膜和胎盘均有表达,但在早产或子痫前期妊娠中无变化。
核心结论
- 早孕期胎盘ACE2与TMPRSS2表达高于妊娠后期,提示妊娠各期对严重急性呼吸综合征冠状病毒2胎盘进入的易感性可能存在差异。
- 尽管有证据显示严重急性呼吸综合征冠状病毒2感染与早产率增加相关,但未发现母胎界面ACE2或TMPRSS2 mRNA表达增加。
研究设计与样本
- 研究纳入两个独立队列共87例妊娠。
- 第一队列为早孕期(7-9周)、中孕期(16-18周)、早产第三孕期(26-31周)及足月第三孕期(38-41周)胎盘,每组n=5。
- 第二队列为匹配的蜕膜与胎盘,来自足月无并发症妊娠(37-41周,n=14)、早产妊娠(26-37周,n=11)及子痫前期妊娠(25-37周,n=42)。
- 采用定量聚合酶链反应和下一代测序或RNA测序定量ACE2与TMPRSS2 mRNA表达。
主要发现
- 第一队列中ACE2与TMPRSS2呈孕龄依赖性表达,早孕期胎盘mRNA高于中孕期、早产及足月胎盘(P<.05),与孕龄呈负相关(P<.05)。
- 第二队列RNA测序显示早产、子痫前期及足月蜕膜和晚孕期胎盘中ACE2表达极低或检测不到。
- TMPRSS2在蜕膜和胎盘样本中均有表达,但在早产或子痫前期妊娠中无变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although there is some evidence that severe acute respiratory syndrome coronavirus 2 can invade the human placenta, limited data exist on the gestational age-dependent expression profile of the severe acute respiratory syndrome coronavirus 2 cell entry mediators, angiotensin-converting enzyme 2 and transmembrane protease serine 2, at the human maternal-fetal interface. There is also no information as to whether the expression of these mediators is altered in pregnancies complicated by preeclampsia or preterm birth. This is important because the expression of decidual and placental angiotensin-converting enzyme 2 and transmembrane protease serine 2 across gestation may affect the susceptibility of pregnancies to vertical transmission of severe acute respiratory syndrome coronavirus 2. OBJECTIVE: This study aimed to investigate the expression pattern of specific severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across human pregnancy and in paired samples of decidua and placenta in pregnancies complicated by preterm birth or preeclampsia compared with those in term uncomplicated pregnancies. STUDY DESIGN: In this study, 2 separate cohorts of patients, totaling 87 pregnancies, were included. The first cohort was composed of placentae from first- (7-9 weeks), second- (16-18 weeks), and third-trimester preterm (26-31 weeks) and third-trimester term (38-41 weeks) pregnancies (n=5/group), whereas the second independent cohort included matched decidua and placentae from pregnancies from term uncomplicated pregnancies (37-41 weeks' gestation; n=14) and pregnancies complicated by preterm birth (26-37 weeks' gestation; n=11) or preeclampsia (25-37 weeks' gestation; n=42). Samples were subjected to quantitative polymerase chain reaction and next-generation sequencing or RNA sequencing for next-generation RNA sequencing for angiotensin-converting enzyme 2 and transmembrane protease serine 2 mRNA expression quantification, respectively. RESULTS: In the first cohort, angiotensin-converting enzyme 2 and transmembrane protease serine 2, exhibited a gestational age-dependent expression profile, that is, angiotensin-converting enzyme 2 and transmembrane protease serine 2 mRNA was higher (P<.05) in the first-trimester placenta than in second-trimester, preterm birth, and term placentae (P<.05) and exhibited a negative correlation with gestational age (P<.05). In the second cohort, RNA sequencing demonstrated very low or undetectable expression levels of angiotensin-converting enzyme 2 in preterm birth, preeclampsia, and term decidua and in placentae from late gestation. In contrast, transmembrane protease serine 2 was expressed in both decidual and placental samples but did not change in pregnancies complicated by either preterm birth or preeclampsia. CONCLUSION: The increased expression of these severe acute respiratory syndrome coronavirus 2 cell entry-associated genes in the placenta in the first trimester of pregnancy compared with those in later stages of pregnancy suggests the possibility of differential susceptibility to placental entry to severe acute respiratory syndrome coronavirus 2 across pregnancy. Even though there is some evidence of increased rates of preterm birth associated with severe acute respiratory syndrome coronavirus 2 infection, we found no increase in mRNA expression of angiotensin-converting enzyme 2 or transmembrane protease serine 2 at the maternal-fetal interface.
引用
- Bloise E, Zhang J, Nakpu J, et al. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia. Am J Obstet Gynecol. 2020. PMID: 32853537. doi:10.1016/j.ajog.2020.08.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。